source
- Biogen's tau therapy shows mixed Alzheimer's results, low dose outperforms higher doseAt the Alzheimer's Association International Conference in London, Biogen presented data on its experimental tau‑targeting therapy for Alzheimer's disease. The trial showed that the drug produced…
- Innovent Biologics partners with Spero to advance autoimmune drug candidate beyond GSK antibioticInnovent Biologics has announced a new partnership with Spero, a smaller biopharma firm, to develop an autoimmune drug candidate originating from Suzhou, China. The collaboration follows a series…